Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

Why criminalizing medical errors is not the answer

The Anesthesia Patient Safety Foundation released a new policy statement detailing why the criminalization of medical errors is unjust and counterproductive.
 

As war in Ukraine continues, it's business as usual for many U.S. healthcare companies in Russia

Since the Russian invasion of Ukraine began in late February, the Yale School of Management has been tracking more than 1,200 companies that do business in Russia.

Michigan has become the 20th state to opt out from federal regulations that require physician supervision of certified registered nurse anesthetists (CRNAs). The move was made to ensure access to value-based, high-quality care across the state, but it is being opposed by the Michigan Society of Anesthesiologists (MSA) and several other physician groups. Image from the American Association of Nurse Anesthesiology (AANA)

Michigan opts out of federal physician supervision of nurse anesthetists

Michigan has become the 20th state to opt out from federal regulations that require physician supervision of certified registered nurse anesthetists. The move is being opposed by anesthesiologists and several other physician groups. 
 

Iodine contrast being loaded into a contrast injector in preparation for a cardiac CT scan at Duly Health and Care in Lisle, Illinois. The contrast shortage is causing some healthcare organizations to postpone exams and procedures and ration contrast supplies. Photo by Dave Fornell

ACR working with FDA and HHS to help address imaging contrast shortage

The American College of Radiology (ACR) announced this week its government relations staff has been engaging federal agencies in an effort to improve product availability and hasten resolution of the ongoing iodine contrast shortage.

How cardiologists can make an impact in the face of anti-abortion laws

“For patients with cardiovascular disease, abortion access is a critical part of their comprehensive cardiovascular and reproductive care,” according to the three authors of a new commentary piece in JAMA Cardiology.

Dartmouth, GraniteOne merger is dead

The news comes after the New Hampshire Attorney General's Office issued a report that it objected to the merger on the basis that it violates New Hampshire law.

Cardiologists join the FDA’s fight against menthol cigarettes, flavored cigars

The American College of Cardiology (ACC), Association of Black Cardiologists, American Heart Association and Society for Cardiovascular Angiography & Interventions are just some of the healthcare organizations supporting the FDA's proposal.

Thumbnail

Moderna CFO out of job after two days

Moderna cited “an ongoing internal investigation into certain matters” in its announcement.

Displaying 609 - 616 of 2773

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup